I hope we'll see a progress
'Biotechnology Victoria e-bulletin' - page 2
'On 9 September 2009, Phosphagenics Ltd (ASX: POH) announced it will start a Phase 2/3 trial of its patented TPM delivery system with the anti-inflammatory drug, diclofenac, in the first quarter of 2010.
The successful completion of the Phase 1B trial this week demonstrated that Phosphagenics' TPM delivery system was able to safely deliver a significantly greater amount of diclofenac into the skin compared to a leading commercial product, Voltaren'.
http://docs.google.com/viewer?a=v&q=cache:6DAbQ9QWUsAJ:www.ausbiotech.org/data/downloads/150909%2520Victorian%2520biotechnology%2520e-bulletin%2520September%25202009%2520(PDF%2520208Kb).pdf+phosphagenics+and+baker+idi&hl=en&gl=au&sig=AHIEtbRggG4qRcZ8q0hP2l51dIrRNWgIkQ
I hope we'll see a progress 'Biotechnology Victoria e-bulletin'...
-
- There are more pages in this discussion • 82 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $9.508M | |||
| Open | High | Low | Value | Volume |
| 0.3¢ | 0.3¢ | 0.3¢ | $6.592K | 2.204M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 53 | 96714175 | 0.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.3¢ | 19678077 | 12 |
View Market Depth
| Last trade - 15.57pm 21/06/2024 (20 minute delay) ? |
| AVE (ASX) Chart |